Size Exclusion Chromatography Analysis of Antibody Drug Conjugates

Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes Application compendium Contents Introduction3 Featured application notes 2 PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mAbs and ADC (5991-7163EN) 5 Intact- and Peptide-Level Characterization of Trastuzumab Emtansine In Vitro…

Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…

Advantages of Agilent AdvanceBio SEC Columns for Biopharmaceutical Analysis Comparing Columns from Different Vendors to Improve Data Quality Technical Overview Introduction Size exclusion chromatography (SEC) is a standard technique for determining molar mass averages, and is often used to describe…

Application Note Biopharma Evaluation of SEC Columns for Analysis of ADC Aggregates and Fragments Choosing the best stationary phase to overcome nonspecific interactions Authors Andrea Angelo P. Tripodi Agilent Technologies, Inc. Church Stretton, UK Arnaud Delobel Quality Assistance S.A. Donstiennes,…